Shafrin Comments on News of Cigna-Express Scripts Merger


Jason Shafrin, senior director at Precision Health Economics, shares his initial thoughts on the merger of Cigna and Express Scripts with NBCNews. He cautions against potential faults with industry consolidation.

To read the full article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.